BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 27743558)

  • 1. Neuropeptide Y as a Biomarker and Therapeutic Target for Neuroblastoma.
    Galli S; Naranjo A; Van Ryn C; Tilan JU; Trinh E; Yang C; Tsuei J; Hong SH; Wang H; Izycka-Swieszewska E; Lee YC; Rodriguez OC; Albanese C; Kitlinska J
    Am J Pathol; 2016 Nov; 186(11):3040-3053. PubMed ID: 27743558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropeptide Y receptor Y5 as an inducible pro-survival factor in neuroblastoma: implications for tumor chemoresistance.
    Czarnecka M; Trinh E; Lu C; Kuan-Celarier A; Galli S; Hong SH; Tilan JU; Talisman N; Izycka-Swieszewska E; Tsuei J; Yang C; Martin S; Horton M; Christian D; Everhart L; Maheswaran I; Kitlinska J
    Oncogene; 2015 Jun; 34(24):3131-43. PubMed ID: 25132261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropeptide Y and its Y2 receptor: potential targets in neuroblastoma therapy.
    Lu C; Everhart L; Tilan J; Kuo L; Sun CC; Munivenkatappa RB; Jönsson-Rylander AC; Sun J; Kuan-Celarier A; Li L; Abe K; Zukowska Z; Toretsky JA; Kitlinska J
    Oncogene; 2010 Oct; 29(41):5630-42. PubMed ID: 20676138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropeptide Y (NPY) in tumor growth and progression: Lessons learned from pediatric oncology.
    Tilan J; Kitlinska J
    Neuropeptides; 2016 Feb; 55():55-66. PubMed ID: 26549645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropeptide Y Y5-receptor activation on breast cancer cells acts as a paracrine system that stimulates VEGF expression and secretion to promote angiogenesis.
    Medeiros PJ; Jackson DN
    Peptides; 2013 Oct; 48():106-13. PubMed ID: 23932937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropeptide y and neuropeptide y y5 receptor interaction restores impaired growth potential of aging bone marrow stromal cells.
    Igura K; Haider HKh; Ahmed RP; Sheriff S; Ashraf M
    Rejuvenation Res; 2011 Aug; 14(4):393-403. PubMed ID: 21595512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropeptide Y receptor interactions regulate its mitogenic activity.
    Czarnecka M; Lu C; Pons J; Maheswaran I; Ciborowski P; Zhang L; Cheema A; Kitlinska J
    Neuropeptides; 2019 Feb; 73():11-24. PubMed ID: 30503694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Y5 receptors mediate neuropeptide Y actions at excitatory synapses in area CA3 of the mouse hippocampus.
    Guo H; Castro PA; Palmiter RD; Baraban SC
    J Neurophysiol; 2002 Jan; 87(1):558-66. PubMed ID: 11784771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropeptide Y stimulates proliferation and migration in the 4T1 breast cancer cell line.
    Medeiros PJ; Al-Khazraji BK; Novielli NM; Postovit LM; Chambers AF; Jackson DN
    Int J Cancer; 2012 Jul; 131(2):276-86. PubMed ID: 21823118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of neuropeptide Y on the growth and vascularization of neural crest-derived tumors.
    Kitlinska J; Abe K; Kuo L; Pons J; Yu M; Li L; Tilan J; Everhart L; Lee EW; Zukowska Z; Toretsky JA
    Cancer Res; 2005 Mar; 65(5):1719-28. PubMed ID: 15753367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropeptide Y/Y5 Receptor Pathway Stimulates Neuroblastoma Cell Motility Through RhoA Activation.
    Abualsaud N; Caprio L; Galli S; Krawczyk E; Alamri L; Zhu S; Gallicano GI; Kitlinska J
    Front Cell Dev Biol; 2020; 8():627090. PubMed ID: 33681186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered expression of neuropeptide Y, Y1 and Y2 receptors, but not Y5 receptor, within hippocampus and temporal lobe cortex of tremor rats.
    Xu X; Guo F; He Q; Cai X; Min D; Wang Q; Wang S; Tian L; Cai J; Zhao Y
    Neuropeptides; 2014 Apr; 48(2):97-105. PubMed ID: 24444822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of neuropeptide Y Y2 and Y5 receptor expression in the mouse hypothalamus.
    Fetissov SO; Byrne LC; Hassani H; Ernfors P; Hökfelt T
    J Comp Neurol; 2004 Mar; 470(3):256-65. PubMed ID: 14755515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropeptide Y Y5 receptor promotes cell growth through extracellular signal-regulated kinase signaling and cyclic AMP inhibition in a human breast cancer cell line.
    Sheriff S; Ali M; Yahya A; Haider KH; Balasubramaniam A; Amlal H
    Mol Cancer Res; 2010 Apr; 8(4):604-14. PubMed ID: 20332211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropeptide Y Peptide Family and Cancer: Antitumor Therapeutic Strategies.
    Sánchez ML; Rodríguez FD; Coveñas R
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular crosstalk between Y5 receptor and neuropeptide Y drives liver cancer.
    Dietrich P; Wormser L; Fritz V; Seitz T; De Maria M; Schambony A; Kremer AE; Günther C; Itzel T; Thasler WE; Teufel A; Trebicka J; Hartmann A; Neurath MF; von Hörsten S; Bosserhoff AK; Hellerbrand C
    J Clin Invest; 2020 May; 130(5):2509-2526. PubMed ID: 31999643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma neuropeptide Y of children with neuroblastoma in relation to stage, age and prognosis, and tissue neuropeptide Y.
    Dötsch J; Christiansen H; Hänze J; Lampert F; Rascher W
    Regul Pept; 1998 Sep; 75-76():185-90. PubMed ID: 9802408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Placental Neuropeptide Y ( NPY) and NPY receptors expressions and serum NPY levels in preeclampsia.
    Klinjampa R; Sitticharoon C; Souvannavong-Vilivong X; Sripong C; Keadkraichaiwat I; Churintaraphan M; Chatree S; Lertbunnaphong T
    Exp Biol Med (Maywood); 2019 Apr; 244(5):380-388. PubMed ID: 30760028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia shifts activity of neuropeptide Y in Ewing sarcoma from growth-inhibitory to growth-promoting effects.
    Tilan JU; Lu C; Galli S; Izycka-Swieszewska E; Earnest JP; Shabbir A; Everhart LM; Wang S; Martin S; Horton M; Mahajan A; Christian D; O'Neill A; Wang H; Zhuang T; Czarnecka M; Johnson MD; Toretsky JA; Kitlinska J
    Oncotarget; 2013 Dec; 4(12):2487-501. PubMed ID: 24318733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropeptide Y and its receptors in prostate cancer: associations with cancer invasiveness and perineural spread.
    Sigorski D; Wesołowski W; Gruszecka A; Gulczyński J; Zieliński P; Misiukiewicz S; Kitlińska J; Iżycka-Świeszewska E
    J Cancer Res Clin Oncol; 2023 Aug; 149(9):5803-5822. PubMed ID: 36583743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.